Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.
RosalindPolley;
SimonaStager;
SaraPrickett;
AsherMaroof;
SoombulZubairi;
Deborah FSmith;
Paul MKaye;
(2006)
Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.
Infection and immunity, 74 (1).
pp. 773-776.
ISSN 0019-9567
DOI: 10.1128/IAI.74.1.773-776.2006
CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.
Item Type | Article |
---|---|
Keywords | Animals, Antigens, Protozoan, immunology, CD8-Positive T-Lymphocytes, immunology, Immunotherapy, Adoptive, Leishmania donovani, genetics, immunology, Leishmaniasis, Visceral, immunology, therapy, Mice, Mice, Transgenic, Ovalbumin, biosynthesis, genetics, Research Support, Non-U.S. Gov't |
ISI | 234276400086 |
Downloads
Full text not available from this repository.
Explore Further
Find work associated with the faculties and division(s):
Find work associated with the research centre(s):
Find work from this publication:
Find other related resources:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346645 (OA Location)
- 10.1128/IAI.74.1.773-776.2006 (DOI)
- 16369038 (PubMed)